The global Pandemic Influenza Vaccine market is projected to grow from US$ 8529.8 million in 2024 to US$ 11790 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Pandemic Influenza Vaccine Market

Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Report Covers:

This report presents an overview of global market for Pandemic Influenza Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pandemic Influenza Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pandemic Influenza Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pandemic Influenza Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pandemic Influenza Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pandemic Influenza Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pandemic Influenza Vaccine Market Report

Report Metric	Details
Report Name	Pandemic Influenza Vaccine Market
Accounted market size in 2024	US$ 8529.8 million
Forecasted market size in 2030	US$ 11790 million
CAGR	5.5
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	6 Months to 3 Years > 3 Years
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pandemic Influenza Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pandemic Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pandemic Influenza Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pandemic Influenza Vaccine Market growing?

Ans: The Pandemic Influenza Vaccine Market witnessing a CAGR of 5.5 during the forecast period 2024-2030.

What is the Pandemic Influenza Vaccine Market size in 2030?

Ans: The Pandemic Influenza Vaccine Market size in 2030 will be US$ 11790 million.

What is the market share of major companies in Pandemic Influenza Vaccine Market?

Ans: The top five players hold a share about 75%.

Who are the main players in the Pandemic Influenza Vaccine Market report?

Ans: The main players in the Pandemic Influenza Vaccine Market are GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Pandemic Influenza Vaccine Market report?

Ans: The Applications covered in the Pandemic Influenza Vaccine Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Pandemic Influenza Vaccine Market report?

Ans: The Types covered in the Pandemic Influenza Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Study Coverage

1.1 Pandemic Influenza Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Market by Application

1.3.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 6 Months to 3 Years

1.3.3 > 3 Years

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Pandemic Influenza Vaccine Revenue by Region

2.2.1 Global Pandemic Influenza Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pandemic Influenza Vaccine Revenue by Region (2019-2024)

2.2.3 Global Pandemic Influenza Vaccine Revenue by Region (2025-2030)

2.2.4 Global Pandemic Influenza Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Pandemic Influenza Vaccine Sales by Region

2.4.1 Global Pandemic Influenza Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pandemic Influenza Vaccine Sales by Region (2019-2024)

2.4.3 Global Pandemic Influenza Vaccine Sales by Region (2025-2030)

2.4.4 Global Pandemic Influenza Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pandemic Influenza Vaccine Sales by Manufacturers

3.1.1 Global Pandemic Influenza Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pandemic Influenza Vaccine in 2023

3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturers

3.2.1 Global Pandemic Influenza Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2023

3.3 Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pandemic Influenza Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pandemic Influenza Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pandemic Influenza Vaccine Sales by Type

4.1.1 Global Pandemic Influenza Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Pandemic Influenza Vaccine Revenue by Type

4.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Pandemic Influenza Vaccine Price by Type

4.3.1 Global Pandemic Influenza Vaccine Price by Type (2019-2024)

4.3.2 Global Pandemic Influenza Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Pandemic Influenza Vaccine Sales by Application

5.1.1 Global Pandemic Influenza Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Pandemic Influenza Vaccine Revenue by Application

5.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Pandemic Influenza Vaccine Price by Application

5.3.1 Global Pandemic Influenza Vaccine Price by Application (2019-2024)

5.3.2 Global Pandemic Influenza Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Pandemic Influenza Vaccine Market Size by Type

6.1.1 US & Canada Pandemic Influenza Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Pandemic Influenza Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Pandemic Influenza Vaccine Market Size by Application

6.2.1 US & Canada Pandemic Influenza Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Pandemic Influenza Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Pandemic Influenza Vaccine Market Size by Country

6.3.1 US & Canada Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pandemic Influenza Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Pandemic Influenza Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pandemic Influenza Vaccine Market Size by Type

7.1.1 Europe Pandemic Influenza Vaccine Sales by Type (2019-2030)

7.1.2 Europe Pandemic Influenza Vaccine Revenue by Type (2019-2030)

7.2 Europe Pandemic Influenza Vaccine Market Size by Application

7.2.1 Europe Pandemic Influenza Vaccine Sales by Application (2019-2030)

7.2.2 Europe Pandemic Influenza Vaccine Revenue by Application (2019-2030)

7.3 Europe Pandemic Influenza Vaccine Market Size by Country

7.3.1 Europe Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pandemic Influenza Vaccine Sales by Country (2019-2030)

7.3.3 Europe Pandemic Influenza Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pandemic Influenza Vaccine Market Size

8.1.1 China Pandemic Influenza Vaccine Sales (2019-2030)

8.1.2 China Pandemic Influenza Vaccine Revenue (2019-2030)

8.2 China Pandemic Influenza Vaccine Market Size by Application

8.2.1 China Pandemic Influenza Vaccine Sales by Application (2019-2030)

8.2.2 China Pandemic Influenza Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pandemic Influenza Vaccine Market Size by Type

9.1.1 Asia Pandemic Influenza Vaccine Sales by Type (2019-2030)

9.1.2 Asia Pandemic Influenza Vaccine Revenue by Type (2019-2030)

9.2 Asia Pandemic Influenza Vaccine Market Size by Application

9.2.1 Asia Pandemic Influenza Vaccine Sales by Application (2019-2030)

9.2.2 Asia Pandemic Influenza Vaccine Revenue by Application (2019-2030)

9.3 Asia Pandemic Influenza Vaccine Sales by Region

9.3.1 Asia Pandemic Influenza Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pandemic Influenza Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Pandemic Influenza Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sanofi

11.1.1 Sanofi Company Information

11.1.2 Sanofi Overview

11.1.3 Sanofi Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sanofi Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Recent Developments

11.2 CSL

11.2.1 CSL Company Information

11.2.2 CSL Overview

11.2.3 CSL Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 CSL Recent Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Overview

11.3.3 GSK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GSK Recent Developments

11.4 Viatris

11.4.1 Viatris Company Information

11.4.2 Viatris Overview

11.4.3 Viatris Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Viatris Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Viatris Recent Developments

11.5 AstraZeneca

11.5.1 AstraZeneca Company Information

11.5.2 AstraZeneca Overview

11.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 AstraZeneca Recent Developments

11.6 Hualan Bio

11.6.1 Hualan Bio Company Information

11.6.2 Hualan Bio Overview

11.6.3 Hualan Bio Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Hualan Bio Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Hualan Bio Recent Developments

11.7 Changchun Institute of Biological

11.7.1 Changchun Institute of Biological Company Information

11.7.2 Changchun Institute of Biological Overview

11.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Changchun Institute of Biological Recent Developments

11.8 Sinovac

11.8.1 Sinovac Company Information

11.8.2 Sinovac Overview

11.8.3 Sinovac Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Sinovac Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Sinovac Recent Developments

11.9 BCHT

11.9.1 BCHT Company Information

11.9.2 BCHT Overview

11.9.3 BCHT Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 BCHT Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 BCHT Recent Developments

11.10 Jiangsu GDK

11.10.1 Jiangsu GDK Company Information

11.10.2 Jiangsu GDK Overview

11.10.3 Jiangsu GDK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Jiangsu GDK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Jiangsu GDK Recent Developments

11.11 KM Biologics

11.11.1 KM Biologics Company Information

11.11.2 KM Biologics Overview

11.11.3 KM Biologics Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 KM Biologics Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 KM Biologics Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pandemic Influenza Vaccine Industry Chain Analysis

12.2 Pandemic Influenza Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pandemic Influenza Vaccine Production Mode & Process

12.4 Pandemic Influenza Vaccine Sales and Marketing

12.4.1 Pandemic Influenza Vaccine Sales Channels

12.4.2 Pandemic Influenza Vaccine Distributors

12.5 Pandemic Influenza Vaccine Customers

13 Market Dynamics

13.1 Pandemic Influenza Vaccine Industry Trends

13.2 Pandemic Influenza Vaccine Market Drivers

13.3 Pandemic Influenza Vaccine Market Challenges

13.4 Pandemic Influenza Vaccine Market Restraints

14 Key Findings in The Global Pandemic Influenza Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Changchun Institute of Biological

List of Tables

Table 1. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Trivalent Influenza Vaccine

Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine

Table 4. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pandemic Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Pandemic Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2019-2024)

Table 9. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2025-2030)

Table 10. Global Pandemic Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Pandemic Influenza Vaccine Sales by Region (2019-2024) & (M Units)

Table 12. Global Pandemic Influenza Vaccine Sales by Region (2025-2030) & (M Units)

Table 13. Global Pandemic Influenza Vaccine Sales Market Share by Region (2019-2024)

Table 14. Global Pandemic Influenza Vaccine Sales Market Share by Region (2025-2030)

Table 15. Global Pandemic Influenza Vaccine Sales by Manufacturers (2019-2024) & (M Units)

Table 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2019-2024)

Table 17. Global Pandemic Influenza Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Pandemic Influenza Vaccine Price by Manufacturers 2019-2024 (US$/Unit)

Table 21. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2023)

Table 23. Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Pandemic Influenza Vaccine, Product Offered and Application

Table 25. Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pandemic Influenza Vaccine Sales by Type (2019-2024) & (M Units)

Table 28. Global Pandemic Influenza Vaccine Sales by Type (2025-2030) & (M Units)

Table 29. Global Pandemic Influenza Vaccine Sales Share by Type (2019-2024)

Table 30. Global Pandemic Influenza Vaccine Sales Share by Type (2025-2030)

Table 31. Global Pandemic Influenza Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Pandemic Influenza Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Pandemic Influenza Vaccine Revenue Share by Type (2019-2024)

Table 34. Global Pandemic Influenza Vaccine Revenue Share by Type (2025-2030)

Table 35. Pandemic Influenza Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Pandemic Influenza Vaccine Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Pandemic Influenza Vaccine Sales by Application (2019-2024) & (M Units)

Table 38. Global Pandemic Influenza Vaccine Sales by Application (2025-2030) & (M Units)

Table 39. Global Pandemic Influenza Vaccine Sales Share by Application (2019-2024)

Table 40. Global Pandemic Influenza Vaccine Sales Share by Application (2025-2030)

Table 41. Global Pandemic Influenza Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Pandemic Influenza Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Pandemic Influenza Vaccine Revenue Share by Application (2019-2024)

Table 44. Global Pandemic Influenza Vaccine Revenue Share by Application (2025-2030)

Table 45. Pandemic Influenza Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Pandemic Influenza Vaccine Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Pandemic Influenza Vaccine Sales by Type (2019-2024) & (M Units)

Table 48. US & Canada Pandemic Influenza Vaccine Sales by Type (2025-2030) & (M Units)

Table 49. US & Canada Pandemic Influenza Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Pandemic Influenza Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Pandemic Influenza Vaccine Sales by Application (2019-2024) & (M Units)

Table 52. US & Canada Pandemic Influenza Vaccine Sales by Application (2025-2030) & (M Units)

Table 53. US & Canada Pandemic Influenza Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Pandemic Influenza Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Pandemic Influenza Vaccine Sales by Country (2019-2024) & (M Units)

Table 59. US & Canada Pandemic Influenza Vaccine Sales by Country (2025-2030) & (M Units)

Table 60. Europe Pandemic Influenza Vaccine Sales by Type (2019-2024) & (M Units)

Table 61. Europe Pandemic Influenza Vaccine Sales by Type (2025-2030) & (M Units)

Table 62. Europe Pandemic Influenza Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Pandemic Influenza Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Pandemic Influenza Vaccine Sales by Application (2019-2024) & (M Units)

Table 65. Europe Pandemic Influenza Vaccine Sales by Application (2025-2030) & (M Units)

Table 66. Europe Pandemic Influenza Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Pandemic Influenza Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Pandemic Influenza Vaccine Sales by Country (2019-2024) & (M Units)

Table 72. Europe Pandemic Influenza Vaccine Sales by Country (2025-2030) & (M Units)

Table 73. China Pandemic Influenza Vaccine Sales by Type (2019-2024) & (M Units)

Table 74. China Pandemic Influenza Vaccine Sales by Type (2025-2030) & (M Units)

Table 75. China Pandemic Influenza Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Pandemic Influenza Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Pandemic Influenza Vaccine Sales by Application (2019-2024) & (M Units)

Table 78. China Pandemic Influenza Vaccine Sales by Application (2025-2030) & (M Units)

Table 79. China Pandemic Influenza Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Pandemic Influenza Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Pandemic Influenza Vaccine Sales by Type (2019-2024) & (M Units)

Table 82. Asia Pandemic Influenza Vaccine Sales by Type (2025-2030) & (M Units)

Table 83. Asia Pandemic Influenza Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Pandemic Influenza Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Pandemic Influenza Vaccine Sales by Application (2019-2024) & (M Units)

Table 86. Asia Pandemic Influenza Vaccine Sales by Application (2025-2030) & (M Units)

Table 87. Asia Pandemic Influenza Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Pandemic Influenza Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Pandemic Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Pandemic Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Pandemic Influenza Vaccine Sales by Region (2019-2024) & (M Units)

Table 93. Asia Pandemic Influenza Vaccine Sales by Region (2025-2030) & (M Units)

Table 94. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Type (2019-2024) & (M Units)

Table 95. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Type (2025-2030) & (M Units)

Table 96. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Application (2019-2024) & (M Units)

Table 99. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Application (2025-2030) & (M Units)

Table 100. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country (2019-2024) & (M Units)

Table 106. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country (2025-2030) & (M Units)

Table 107. Sanofi Company Information

Table 108. Sanofi Description and Major Businesses

Table 109. Sanofi Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Sanofi Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Sanofi Recent Developments

Table 112. CSL Company Information

Table 113. CSL Description and Major Businesses

Table 114. CSL Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. CSL Recent Developments

Table 117. GSK Company Information

Table 118. GSK Description and Major Businesses

Table 119. GSK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. GSK Recent Developments

Table 122. Viatris Company Information

Table 123. Viatris Description and Major Businesses

Table 124. Viatris Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Viatris Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Viatris Recent Developments

Table 127. AstraZeneca Company Information

Table 128. AstraZeneca Description and Major Businesses

Table 129. AstraZeneca Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. AstraZeneca Recent Developments

Table 132. Hualan Bio Company Information

Table 133. Hualan Bio Description and Major Businesses

Table 134. Hualan Bio Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Hualan Bio Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Hualan Bio Recent Developments

Table 137. Changchun Institute of Biological Company Information

Table 138. Changchun Institute of Biological Description and Major Businesses

Table 139. Changchun Institute of Biological Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Changchun Institute of Biological Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Changchun Institute of Biological Recent Developments

Table 142. Sinovac Company Information

Table 143. Sinovac Description and Major Businesses

Table 144. Sinovac Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Sinovac Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Sinovac Recent Developments

Table 147. BCHT Company Information

Table 148. BCHT Description and Major Businesses

Table 149. BCHT Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. BCHT Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. BCHT Recent Developments

Table 152. Jiangsu GDK Company Information

Table 153. Jiangsu GDK Description and Major Businesses

Table 154. Jiangsu GDK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Jiangsu GDK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Jiangsu GDK Recent Developments

Table 157. KM Biologics Company Information

Table 158. KM Biologics Description and Major Businesses

Table 159. KM Biologics Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. KM Biologics Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. KM Biologics Recent Developments

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Pandemic Influenza Vaccine Distributors List

Table 165. Pandemic Influenza Vaccine Customers List

Table 166. Pandemic Influenza Vaccine Market Trends

Table 167. Pandemic Influenza Vaccine Market Drivers

Table 168. Pandemic Influenza Vaccine Market Challenges

Table 169. Pandemic Influenza Vaccine Market Restraints

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. Pandemic Influenza Vaccine Product Picture

Figure 2. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pandemic Influenza Vaccine Market Share by Type in 2023 & 2030

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pandemic Influenza Vaccine Market Share by Application in 2023 & 2030

Figure 8. 6 Months to 3 Years

Figure 9. > 3 Years

Figure 10. Pandemic Influenza Vaccine Report Years Considered

Figure 11. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Pandemic Influenza Vaccine Revenue 2019-2030 (US$ Million)

Figure 13. Global Pandemic Influenza Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2019-2030)

Figure 15. Global Pandemic Influenza Vaccine Sales 2019-2030 ((M Units)

Figure 16. Global Pandemic Influenza Vaccine Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Pandemic Influenza Vaccine Sales YoY (2019-2030) & (M Units)

Figure 18. US & Canada Pandemic Influenza Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Pandemic Influenza Vaccine Sales YoY (2019-2030) & (M Units)

Figure 20. Europe Pandemic Influenza Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Pandemic Influenza Vaccine Sales YoY (2019-2030) & (M Units)

Figure 22. China Pandemic Influenza Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Pandemic Influenza Vaccine Sales YoY (2019-2030) & (M Units)

Figure 24. Asia (excluding China) Pandemic Influenza Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales YoY (2019-2030) & (M Units)

Figure 26. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Pandemic Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Pandemic Influenza Vaccine in the World: Market Share by Pandemic Influenza Vaccine Revenue in 2023

Figure 29. Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

Figure 31. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

Figure 32. Global Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

Figure 33. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Pandemic Influenza Vaccine Revenue Share by Country (2019-2030)

Figure 39. US & Canada Pandemic Influenza Vaccine Sales Share by Country (2019-2030)

Figure 40. U.S. Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

Figure 43. Europe Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

Figure 44. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

Figure 45. Europe Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

Figure 46. Europe Pandemic Influenza Vaccine Revenue Share by Country (2019-2030)

Figure 47. Europe Pandemic Influenza Vaccine Sales Share by Country (2019-2030)

Figure 48. Germany Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 49. France Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. China Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

Figure 54. China Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

Figure 55. China Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

Figure 56. China Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

Figure 57. Asia Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

Figure 58. Asia Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

Figure 59. Asia Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

Figure 60. Asia Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

Figure 61. Asia Pandemic Influenza Vaccine Revenue Share by Region (2019-2030)

Figure 62. Asia Pandemic Influenza Vaccine Sales Share by Region (2019-2030)

Figure 63. Japan Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. India Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales Share by Country (2019-2030)

Figure 74. Brazil Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Pandemic Influenza Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Pandemic Influenza Vaccine Value Chain

Figure 80. Pandemic Influenza Vaccine Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions